Active ingredientBiapenemCat. No. P-B073-001CAS 120410-24-4Family · Pharmaceutical analytical standards
Biapenem
A broad-spectrum carbapenem antibiotic developed in Japan in the late 1980s and approved there in 2001; it is given intravenously and is active against many Gram-positive and Gram-negative bacteria. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Unlike imipenem it resists the kidney enzyme dehydropeptidase-I: so it does not need to be combined with cilastatin, which is used precisely to protect imipenem.
Go to the active ingredient →Active ingredientBiapenemCat. No. P-B073-001CAS 120410-24-4
Isotopically labelledBiapenem-13C2,15N3Cat. No. P-B073-003
Impurity1,2-di(pyrazolidin-4-yl)disulfaneCat. No. P-B073-005CAS 756788-21-3
ImpurityBiapenem Side ChainCat. No. P-B073-006CAS 153851-71-9
ImpurityBiapenem Dimer BCat. No. P-B073-008
ImpurityBiapenem Impurity 1Cat. No. P-B073-009CAS 162559-31-1
ImpurityBiapenem Impurity 2Cat. No. P-B073-024CAS 2524614-58-0
ImpurityBiapenem Impurity 3Cat. No. P-B073-025CAS 141499-33-4
ImpurityBiapenem Impurity 5Cat. No. P-B073-034
ImpurityPyrazolidine-4-thiolCat. No. P-B073-035CAS 163805-05-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.